Status:
COMPLETED
Is Betwixt App Effective and Acceptable?
Lead Sponsor:
University of Nottingham
Collaborating Sponsors:
Lincolnshire Partnership NHS Foundation Trust
Conditions:
Depression - Major Depressive Disorder
ANXIETY DISORDERS (or Anxiety and Phobic Neuroses)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Title Is the Betwixt application effective and acceptable in improving emotion regulation for an adult clinical population? Short title Betwixt: Effective/acceptable clinical population emotion regula...
Detailed Description
Study Background Information and Rationale Mental health problems are one of the main causes of overall disease burden globally (7.4%) (more than HIV/AIDs and tuberculosis, diabetes, and transport inj...
Eligibility Criteria
Inclusion
- Adults (aged 18 years and above).
- Currently on the waiting list for a specific IAPT service.
- Experiencing an anxiety disorder and/or depression (scoring 10 or above on the Patient Health Questionnaire-9 (PHQ-9) (Kroenke et al., 2001) measure for depression or scoring eight or above on the Generalised Anxiety Disorder-7 (GAD-7) (Spitzer et al., 2006) measure for anxiety) (The National Collaborating Centre for Mental Health, 2021), when assessed by the IAPT service.
- Own a mobile phone they can use Betwixt on.
- Comfortable with using a phone for extended periods of time.
- Able to give informed consent.
Exclusion
- Sufficient English reading ability, due to the narrative nature of Betwixt. This will be ascertained by ensuring that the participant can read and understand the PIS, and information outlining the narrative nature of Betwixt will also be included.
- Available for up to seven weeks whilst on the IAPT waiting list. There is flexibility, for example, if a participant has a planned holiday whilst on the IAPT waiting list, the study can be delayed for two weeks (if the waiting time allows).
Key Trial Info
Start Date :
April 8 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 11 2024
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT06958887
Start Date
April 8 2024
End Date
October 11 2024
Last Update
May 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lincolnshire Partnership Foundation Trust
Lincoln, UK, United Kingdom, LN1 1FS